Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
Kensei Tobinai, Michinori Ogura, Dai Maruyama, Toshiki Uchida, Naokuni Uike, Ilseung Choi, Kenichi Ishizawa, Kuniaki Itoh, Kiyoshi Ando, Masafumi Taniwaki, Naomi Shimada, Ken KobayashiVolume:
92
Language:
english
Pages:
8
DOI:
10.1007/s12185-010-0707-5
Date:
November, 2010
File:
PDF, 345 KB
english, 2010